Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > 16.5 cents close today

<< Previous

Bullboard Posts

Next >>

Comment by Kayz88on Jul 18, 2024 9:57pm

223 Views

Post# 36139453

RE:RE:RE:RE:16.5 cents close today

No, it's not necessary for the final approval. It's absolutely necessary to keep this company afloat. It's a rubberstamp that has the highest probability to raise the stock price so they can raise actual money. If they keep with these small PPs once per quarter, that's another 8 quarters, that's 8 more raises, 8 times more dilution.

<< Previous

Bullboard Posts

Next >>

Gold vs. bitcoin, where should you invest?